Penumbra, Inc Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Penumbra, Inc (PEN) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $30.10 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-02-25
- Penumbra, Inc share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2022-03-31 was $17.57, a 11.91% increase year-over-year.
- Penumbra, Inc share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2021-03-31 was $15.70, a 70.10% increase year-over-year.
- Penumbra, Inc share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2020-03-31 was $9.23, a 22.89% decline year-over-year.
- Penumbra, Inc share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2019-03-31 was $11.97, a 5.74% increase year-over-year.
- Penumbra, Inc share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $30.10, a 25.26% increase from fiscal 2024.
- Penumbra, Inc share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $24.03, a 4.30% increase from fiscal 2023.
- Penumbra, Inc share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $23.04, a 8.75% decline from fiscal 2022.
- Penumbra, Inc share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $25.25, a 82.71% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2025-12-31 | $30.10 10-K · filed 2026-02-25 | |||
| 2024-12-31 | $24.03 10-K · filed 2025-02-18 | |||
| 2023-12-31 | $23.04 10-K · filed 2024-02-22 | |||
| 2022-12-31 | $25.25 10-K · filed 2023-02-23 | |||
| 2022-09-30 | $24.80 10-Q · filed 2022-11-03 | |||
| 2022-06-30 | $24.32 10-Q · filed 2022-08-05 | |||
| 2022-03-31 | $17.57 10-Q · filed 2022-05-03 | |||
| 2021-12-31 | $13.82 10-K · filed 2022-02-22 | |||
| 2021-09-30 | $14.99 10-Q · filed 2021-11-03 | |||
| 2021-06-30 | $13.92 10-Q · filed 2021-08-09 | |||
| 2021-03-31 | $15.70 10-Q · filed 2021-05-04 | |||
| 2020-12-31 | $14.28 10-K · filed 2021-02-23 | |||
| 2020-09-30 | $14.20 10-Q · filed 2020-11-02 | |||
| 2020-06-30 | $13.12 10-Q · filed 2020-08-03 | |||
| 2020-03-31 | $9.23 10-Q · filed 2020-05-07 | |||
| 2019-12-31 | $13.12 10-K · filed 2020-02-26 | |||
| 2019-09-30 | $12.69 10-Q · filed 2019-11-07 | |||
| 2019-06-30 | $12.08 10-Q · filed 2019-08-06 | |||
| 2019-03-31 | $11.97 10-Q · filed 2019-05-07 | |||
| 2018-12-31 | $12.16 10-K · filed 2019-02-26 | |||
| 2018-09-30 | $12.32 10-Q · filed 2018-11-05 | |||
| 2018-06-30 | $12.97 10-Q · filed 2018-08-07 | |||
| 2018-03-31 | $11.32 10-Q · filed 2018-05-08 | |||
| 2017-12-31 | $6.54 10-K · filed 2018-02-27 | |||
| 2017-09-30 | $6.21 10-Q · filed 2017-11-07 | |||
| 2017-06-30 | $4.79 10-Q · filed 2017-08-08 | |||
| 2017-03-31 | $2.73 10-Q · filed 2017-05-09 | |||
| 2016-12-31 | $3.62 10-K · filed 2017-02-28 | |||
| 2016-09-30 | $3.45 10-Q · filed 2016-11-03 | |||
| 2016-06-30 | $5.80 10-Q · filed 2016-08-09 | |||
| 2016-03-31 | $2.36 10-Q · filed 2016-05-09 | |||
| 2015-12-31 | $0.99 10-K · filed 2016-03-08 | |||
| 2015-09-30 | $0.95 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |